CLINICAL MANIFESTATIONS AND RISK-FACTORS OF PSEUDOMONAS-AERUGINOSA INFECTION IN PATIENTS WITH AIDS

被引:64
作者
DROPULIC, LK [1 ]
LESLIE, JM [1 ]
ELDRED, LJ [1 ]
ZENILMAN, J [1 ]
SEARS, CL [1 ]
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV INFECT DIS,BALTIMORE,MD 21205
关键词
D O I
10.1093/infdis/171.4.930
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fifty-eight patients with human immunodeficiency virus infection were analyzed for clinical manifestations and potential risk factors for Pseudomonas aeruginosa infection by use of case-control methodology. Most had AIDS. Of 73 episodes of P. aeruginosa infection, 45 (62%) were bacteremias primarily associated with central venous catheters (16), pneumonia (12), soft tissue (4), or urinary tract infections (4). Twenty-eight episodes (38%) were nonbacteremic, with pneumonia (13), soft tissue infections (6), and sinusitis (4) accounting for the majority of infections. Fifty episodes (68%) were community-acquired. The recurrence rate was 23%. The overall mortality attributable to P. aeruginosa infection was 22%. Central venous and urinary catheter use and steroid therapy were significantly more frequent in cases than controls (P < .05). Thus, P. aeruginosa infection in patients with advanced human immunodeficiency virus disease is often community-acquired and associated with substantial mortality and, in some cases, specific risk factors.
引用
收藏
页码:930 / 937
页数:8
相关论文
共 24 条
  • [1] PSEUDOMONAS-AERUGINOSA BRONCHOPULMONARY INFECTION IN LATE HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE
    BARON, AD
    HOLLANDER, H
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04): : 992 - 996
  • [2] BODEY GP, 1983, REV INFECT DIS, V5, P279
  • [3] A CONTROLLED TRIAL OF EARLY ADJUNCTIVE TREATMENT WITH CORTICOSTEROIDS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    BOZZETTE, SA
    SATTLER, FR
    CHIU, J
    WU, AW
    GLUCKSTEIN, D
    KEMPER, C
    BARTOK, A
    NIOSI, J
    ABRAMSON, I
    COFFMAN, J
    HUGHLETT, C
    LOYA, R
    CASSENS, B
    AKIL, B
    MENG, TC
    BOYLEN, CT
    NIELSEN, D
    RICHMAN, DD
    TILLES, JG
    LEEDOM, J
    MCCUTCHAN, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (21) : 1451 - 1457
  • [4] CHAISSON RE, 1992, MED MANAGEMENT AIDS, P346
  • [5] IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX - A COMPREHENSIVE EVALUATION
    ELLIS, M
    GUPTA, S
    GALANT, S
    HAKIM, S
    VANDEVEN, C
    TOY, C
    CAIRO, MS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) : 1268 - 1276
  • [6] BACTEREMIA AND FUNGEMIA IN PATIENTS WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME
    ENG, RHK
    BISHBURG, E
    SMITH, SM
    GELLER, H
    KAPILA, R
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 86 (01) : 105 - 107
  • [7] SERIOUS PSEUDOMONAS-AERUGINOSA INFECTIONS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - A CASE-CONTROL STUDY
    FICHTENBAUM, CJ
    WOELTJE, KF
    POWDERLY, WG
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 19 (03) : 417 - 422
  • [8] A CONTROLLED TRIAL OF TRIMETHOPRIM SULFAMETHOXAZOLE OR AEROSOLIZED PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME - AIDS CLINICAL-TRIALS GROUP PROTOCOL-021
    HARDY, WD
    FEINBERG, J
    FINKELSTEIN, DM
    POWER, ME
    HE, W
    KACZKA, C
    FRAME, PT
    HOLMES, M
    WASKIN, H
    FASS, RJ
    POWDERLY, WG
    STEIGBIGEL, RT
    ZUGER, A
    HOLZMAN, RS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (26) : 1842 - 1848
  • [9] KATZ S, 1990, AM J MED, V88
  • [10] INVIVO EFFICACY OF ZIDOVUDINE (3'-AZIDO-3'-DEOXYTHYMIDINE) IN EXPERIMENTAL GRAM-NEGATIVE-BACTERIAL INFECTIONS
    KEITH, BR
    WHITE, G
    WILSON, HR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (04) : 479 - 483